|4Sep 27, 6:36 PM ET

Connealy Pamela Ann 4

4 · Pyxis Oncology, Inc. · Filed Sep 27, 2023

Insider Transaction Report

Form 4
Period: 2023-09-27
Transactions
  • Purchase

    Common Stock

    2023-09-27$1.85/sh+6,426$11,868810,532 total
Footnotes (1)
  • [F1]Represents the weighted average purchase price of common stock purchased by the Reporting Person in open market transactions. The range of purchase prices on the transaction date was $1.78 to $1.87 per share. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each price.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION